As a heavy metal that widely exists in nature, Cd is a highly toxic pollutant that can enter the human body through biological enrichment and cause serious damage. Given its long half-life, Cd can persist in the body, and thus, it is classified as human class I carcinogen by the National Toxicology Program of the United States[25]. The liver is one of the important organs in humans and animals[26]. Given its powerful metabolic function, the liver is also an important target organ of Cd poisoning. Cd ingested by the body accumulates in the liver, frequently causing liver hemorrhage and edema, and in serious cases, it can lead to hepatocyte apoptosis and necrosis[27]. Studies have shown that the antioxidant function of Que can resist and alleviate the short-term toxicity caused by Cd[15, 28]. Moreover, Que’s function of inhibiting ROS generation, antioxidation, and autophagy plays a protective role against Cd-induced testicular toxicity[29]. Que can alleviate Cd-induced apoptosis[23], but the specific mechanism remains unclear. 4-PBA is an ERS inhibitor that can reduce the occurrence of ERS by regulating the folding ability of ER folding protein and inhibiting oxidative stress[30]. Therefore, on the basis of the establishment of rat BRL-3A cell Cd poisoning and a Que treatment model, this experiment uses the ERS inhibitor 4-PBA to further explore the specific mechanism of Que in alleviating Cd-induced BRL-3A cell apoptosis.
We performed cytotoxicity tests after selecting the appropriate concentrations of Cd (Fig. 1A), Que (Fig. 1B), and 4-PBA (Figs. 1C and 1D) from previous studies and repeated experiments[21, 23]. The significant reduction in cell viability in the Cd treated group demonstrates the important toxic effect of Cd on hepatocyte injury (Fig. 1E). However, the recovery of BRL-3A cell viability in the combined treatment groups of Cd and Que and Cd and 4-PBA confirmed the protective effect of Que against Cd toxicity. We speculated that such effect was related to the inhibition of the occurrence of ERS. From the observation experiments on BRL-3A cell morphology, we can conclude that Cd treatment (Fig. 2B) triggered cellular Cd poisoning, leading to disorganized cell alignment, the disappearance of intercellular junctions, and incomplete morphology. Meanwhile, the addition of Que (Fig. 2C) or 4-PBA (Fig. 2E) can effectively alleviate the toxic effects of Cd.
Previous studies have found that the primary pathway by which Cd exerts toxicity is by activating oxidative stress[29, 31, 32]. Cd can cause cell viability reduction by regulating the body’s ROS levels, and a large aggregation of ROS is an important cause of cell apoptosis[33, 34]. Through the detection of intracellular ROS levels, we determined that Cd treatment significantly elevated the ROS levels of BRL-3A cells (Fig. 3B), leading to the occurrence of oxidative stress. By contrast, the addition of Que (Fig. 3C) or 4-PBA (Fig. 3E) effectively alleviated cellular ROS levels and reduced oxidative stress, further confirming the antioxidant effect of Que. Previous studies have found that by disrupting the balance of intracellular oxidative stress[33], Cd can further induce an apoptotic cascade, which is an important mechanism of Cd cytotoxicity. Apoptosis, a cell autonomous death regulated by genes, is an important regulatory technique used for self-recovery after body injury. Apoptosis plays an important role in regulating the homeostasis of the body[35]. Through Hoechst 33342 staining (Figs. 4A and 4B), we determined that the fluorescence intensity of the cells in the group treated with Cd considerably increased and the cells exhibited apoptotic morphologies. Cell shrinkage, fragmentation, and nuclear chromatin condensation can be observed under fluorescence microscopy. Meanwhile, BRL-3A cell morphologies in the combined treatment groups of Cd and Que and Cd and 4-PBA were all restored to nearly the same condition as the cells in the control group; apoptosis was alleviated, confirming the occurrence of apoptosis caused by Cd from the morphological perspective[36]. Meanwhile Que inhibited apoptosis. However, what is the specific mechanism by which Que alleviates apoptosis? We conducted subsequent experimental explorations to answer this question.
In accordance with previous reports, Cd-induced liver apoptosis has three major pathways. The ER-mediated apoptosis pathway refers to the apoptosis caused by the occurrence of ERS and the failure of the homeostasis of the organism environment to recover in time. A large amount of ROS accumulation will lead to the imbalance of oxidation and antioxidant levels in the body, and ultimately, to ERS[13, 37]. The occurrence of ERS apoptosis primarily depends on the release of GRP78 and its combination with downstream targets[38], resulting in PERK/IRE1α/ATF6 signal pathways[39–41]. An increasing amount of evidence has shown that when ERS is not addressed, UPR may lead to cell death by inducing inflammatory body activation and apoptosis, leading to metabolic diseases, such as fatty liver[42]. The activation of the caspase cascade is an important pathway for ERS to mediate apoptosis. Among them, Caspase-12 is a key factor that widely exists in the liver and kidneys and has a high expression level[43]. The activation of Caspase-12 is specifically caused by ER damage. Recombinant Caspase-12 can activate Caspase-3 and other effector caspases, eventually leading to apoptosis. Caspase-12-mediated apoptosis is an important pathway of ERS-induced apoptosis[44]. This process is also regulated by members of the Bcl2 cell lymphoma protein family. Bax is a pro-apoptotic protein, whereas Bcl2 is an anti-apoptotic protein. Bax and Bcl2 are considered the key genes that regulate apoptosis and can directly reflect the degree of apoptosis.
To explore whether Que can alleviate Cd-induced apoptosis by inhibiting ERS, we first performed qRT-PCR to detect the mRNA expression level of ERS (Figs. 5 and 7). After Cd treatment, the mRNA expression levels of ERS-related genes increased significantly, activating the ERS signaling pathway. Then, by activating the mRNA expression levels of Caspase-12 and Caspase-3, the expression level of Bax increased significantly, whereas the expression level of Bcl2 decreased significantly, eventually leading to apoptosis. Compared with the control group, the mRNA expression levels of ERS-related genes in the combined treatment group of Cd and Que were significantly decreased, proving that the addition of Que can effectively reduce the increased mRNA expression levels of ERS-related genes induced by Cd toxicity. The mRNA expression levels of ERS-related genes in the combined treatment group of Cd and 4-PBA were considerably lower than those in the control group, also proving that 4-PBA can significantly alleviate the increase in mRNA expression levels of ERS-related genes caused by Cd. The mRNA expression levels of Caspase-12, Caspase-3, and Bax in the combined treatment group of Cd and Que were reduced considerably and the mRNA expression level of Bcl2 was increased remarkably compared with those in the control group, proving that Que reduced the mRNA expression levels of apoptosis-related genes by inhibiting the mRNA expression levels of ERS-related genes. The mRNA expression levels of Caspase-12, Caspase-3, and Bax in the combined treatment group of Cd and 4-PBA were also reduced remarkably and the mRNA expression level of Bcl2 was also increased considerably than those in the control group, also proving that 4-PBA inhibited the mRNA expression levels of apoptosis-related genes by inhibiting the mRNA expression levels of ERS-related genes. Therefore, we speculate that Que can alleviate the apoptosis of BRL-3A cells induced by Cd by decreasing the mRNA expression levels of ERS-related genes.
For further verification, we performed Western blot to detect the expression of ERS and apoptosis-related proteins (Figs. 6 and 8, respectively). The experimental results indicated that Cd treatment led to a significant increase in the expression levels of ERS-related proteins, Caspase-12, Caspase-3 and Bax proteins, and a decrease in the expression level of Bcl2, proving that Cd treatment leads to an increase in the expression levels of ERS-related proteins; it activates ERS, which ultimately leads to the improvement of the expression levels of apoptosis-related proteins and causes apoptosis[45]. The addition of Que or 4-PBA can considerably reduce the expression levels of ERS-related proteins, significantly reducing the expression levels of Caspase-12, Caspase-3, and Bax proteins, and remarkably increasing the expression level of Bcl2 protein, proving that Que and 4-PBA can inhibit the expression levels of apoptosis-related proteins by inhibiting the expression of ERS-related proteins. This study clearly demonstrated that Que can reduce apoptosis-related protein expression in BRL-3A cells by inhibiting the expression levels of ERS-related proteins and then alleviating apoptosis. Meanwhile, the role of Que is similar to that of an ERS inhibitor. Combined with the qRT-PCR and Western blot results, we determined that Que can alleviate Cd-induced apoptosis by inhibiting the PERK/IRE1α/ATF6 ERS signaling pathway, in which the effect of Que was similar to that of 4-PBA.